The global pneumonia testing market was valued at over USD 1 billion in 2016 and is anticipated to surpass USD 2 billion by 2021, says Technavio.
Technavio has published its current industry research analysis on the global pneumonia testing market, under its in-vitro diagnostics portfolio. This market research analysis consists of the key drivers and main emerging trends and provides a breakdown of key sellers like Abbott Molecular, bioMérieux, Becton, Dickenson, and Company (BD), Roche Molecular Diagnostics, and Thermo Fisher Scientific.
According to Barath Palada, a lead analyst for in-vitro diagnostics research at Technavio, “The rising popularity of POC testing will fuel the growth in the pneumonia testing market during the forecast period. POC technology facilitates data storage, data sharing, and communication with public health agencies. The processing of accurate data on the prevalence of pneumonia in a community could help restrain the inappropriate use of antibiotics and improve the allocation of vaccines to areas with the highest need. Such advantages of POC testing will revolutionize the healthcare industry.”
The vendors in the market are focusing on research and development to increase their product portfolio and launch innovative drugs. Such initiatives will increase the availability of the number of POC pneumonia testing products in the global market. Moreover, vendor partnerships will improve the services provided by various healthcare institutions.
Click here to request a free sample of this report
Increase in adoption of molecular diagnostic testing
The introduction of molecular diagnostic testing will improve the precision, sensitivity, efficiency, and speed of clinical diagnostic procedures. This testing method will help reduce the recovery time and healthcare expenditure of the patients. Leading vendors in the market are offering fast, easy, and comprehensive molecular testing technology that integrates sample preparation, amplification, detection, and analysis. These systems are designed to provide extraction, amplification, and detection in a closed system, which minimizes contamination and provides accurate results.
Growing consumer shift toward direct-to-consumer testing
The convenience of direct-to-consumer testing will augment the growth of the global pneumonia testing market. The market is primarily driven by the growth in the number of health-conscious individuals who are looking for direct access to various laboratory tests for self-assessment or evaluation of their body conditions. Some of the testing models offered by various vendors allow users to order various tests online without doctor’s prescription.
Ask an analyst to know more about this report
This research study includes an exhaustive analysis of the market shares and sizes of the sub-sections and geography. A breakdown of the main businesses, including their key financials, market shares, business overview, etc. is provided in this study. This market report also provides a complete study of key drivers, challenges, and opportunities influencing this market.
A detailed report is available in the Technavio report titled, ‘Global Pneumonia Testing Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Human Respiratory Syncytial Virus Drugs Market 2016-2020
- Remote Health Delivery Market in India 2016-2020
- Global Chronic Obstructive Pulmonary Disease Drug Market 2016-2020
To read more press releases – click here
